<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Article Authoring DTD v1.4 20240229//EN" "JATS-articleauthoring1.dtd">
<article article-type="research-article" xml:lang="zh-CN" xmlns:xlink="http://www.w3.org/1999/xlink">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">19</journal-id>
      <journal-title-group>
        <journal-title>医学研究</journal-title>
      </journal-title-group>
      <issn>2661-359X</issn>
      <publisher>
        <publisher-name>华文科学出版社</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.12421/yxyj2661-3603-2025-7-103</article-id>
      <article-id pub-id-type="publisher-id">12820</article-id>
      <title-group>
        <article-title>头孢哌酮钠舒巴坦钠联合莫西沙星治重症肺炎临床疗效</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <string-name>马瑞静 (赤峰平民医院 内蒙古赤峰 024000)</string-name>
        </contrib>
      </contrib-group>
      <pub-date pub-type="epub">
        <year>2025</year>
        <month>4</month>
      </pub-date>
      <issue>4</issue>
      <abstract>
        <p>目的：探讨重症肺炎经头孢哌酮钠舒巴坦钠联合莫西沙星治疗重症肺炎效果。方法：将医院60例重症肺炎患者分成对照组及观察组， 对照组单用头孢哌酮钠舒巴坦钠，观察组联合莫西沙星，观察疗效。结果：观察组评估治疗有效率高于对照组，且血清炎性因子、肺氧合 功能指标改善效果均显著高于对照组，不良反应发生率低（P</p>
      </abstract>
    </article-meta>
  </front>
</article>
